List of insiders holdings for SURMODICS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
1 | Ramius LLC RAMIUS ADVISORS LLC RAMIUS VALUE & OPPORTUNITY MASTER FUND LTD Ramius Value & Opportunity Advisors LLC Cowen Overseas Investment LP 10% Owner | 2011-01-06 17:17:19 | 2,088,760 0 | 2,088,760 | Form 13D |
2 | Ramius LLC C4S & CO LLC COHEN PETER A STARK MORGAN B STRAUSS THOMAS W SOLOMON JEFFREY M COWEN GROUP INC. RCG HOLDINGS LLC 10% Owner | 2011-01-06 17:17:19 | 2,088,760 0 | 2,088,760 | Form 13D |
3 | OLSETH DALE R Director | 2011-02-11 14:01:47 | 760,619 0 | 760,619 | Form 13G |
4 | GUIRE PATRICK E Senior Vice President | 2004-11-12 12:40:49 | 242,329 132,490 | 374,819 | Form 5 |
5 | KOCH DAVID A Director | 2009-01-20 14:38:03 | 325,003 0 | 325,003 | Form 13G |
6 | Maharaj Gary R President & CEO | 2024-12-06 16:46:00 | 192,056 0 | 192,056 | Form 4 |
7 | VERSEN MARIE J VP Qual Mgmt & Reg Compliance | 2005-02-02 14:45:51 | 90,514 0 | 90,514 | Form 4 |
8 | Arens Timothy J. Chief Financial Officer | 2024-12-06 16:47:16 | 67,299 0 | 67,299 | Form 4 |
9 | MILLER LOREN R Vice President and Controller | 2007-08-15 14:33:39 | 62,369 0 | 62,369 | Form 4 |
10 | ANKENY PHILIP D Interim CEO, Senior VP & CFO | 2010-12-02 18:17:05 | 61,983 0 | 61,983 | Form 4 |
11 | Stich Joseph J. SVP of HR, President IVD | 2024-12-06 16:42:08 | 61,631 0 | 61,631 | Form 4 |
12 | BARCLAY BRUCE President & CEO | 2010-02-10 12:54:29 | 56,880 0 | 56,880 | Form 4 |
13 | Wood David S VP & GM - Drug Del. Bus. Unit | 2006-03-22 16:56:03 | 56,808 0 | 56,808 | Form 4 |
14 | OLSON CHARLES W SVP, Medical Device Coatings | 2024-12-06 16:41:37 | 51,478 800 | 52,278 | Form 4 |
15 | OFSTEAD RONALD F VP Chemistry Development | 2004-01-29 16:33:59 | 51,910 0 | 51,910 | Form 4 |
16 | YUNG GREGORY T VP Sales & Marketing | 2005-02-02 14:08:22 | 50,415 0 | 50,415 | Form 4 |
17 | Greaney Thomas A. COO of Medical Devices | 2019-11-27 15:25:33 | 45,681 0 | 45,681 | Form 4 |
18 | CARLSON RICHARD C VP of Strategic Planning | 2004-02-04 13:51:01 | 44,752 0 | 44,752 | Form 4 |
19 | KALICH RONALD B SR Director | 2024-02-12 16:12:46 | 42,131 0 | 42,131 | Form 4 |
20 | LaFrence Andrew D. C. VP of Finance & CFO | 2017-11-30 20:24:59 | 41,771 0 | 41,771 | Form 4 |
21 | Starboard Value LP Starboard Value GP LLC Starboard Principal Co LP Starboard Principal Co GP LLC Smith Jeffrey C MITCHELL MARK R Feld Peter A STARBOARD VALUE & OPPORTUNITY MASTER FUND LTD See Footnote 1. 10% Owner | 2012-09-10 17:24:50 | 41,412 0 | 41,412 | Form 13D |
22 | DANTZKER DAVID Director | 2025-02-18 17:22:54 | 40,183 0 | 40,183 | Form 4 |
23 | KNIGHT SUSAN E Director | 2025-01-28 17:39:47 | 37,240 0 | 37,240 | Form 4 |
24 | Phillips Bryan K SVP, Gen Counsel & Secretary | 2019-12-02 16:10:20 | 35,311 0 | 35,311 | Form 4 |
25 | SIDES TERI WOODWICK SVP, Vascular Interventions | 2024-12-06 16:43:16 | 34,703 0 | 34,703 | Form 4 |
26 | TIPTON ARTHUR J VP, Pres of Pharmaceuticals | 2010-12-02 18:36:14 | 30,991 0 | 30,991 | Form 4 |
27 | BEDOYA JOSE H Director | 2025-02-18 17:20:51 | 30,008 0 | 30,008 | Form 4 |
28 | Webster Jan M VP of HR | 2010-12-02 18:38:25 | 27,548 0 | 27,548 | Form 4 |
29 | Rusch Eugene C. VP, Manufacturing | 2010-12-02 18:31:17 | 27,548 0 | 27,548 | Form 4 |
30 | Sutton Gregg S VP of Research and Development | 2019-12-02 16:11:38 | 25,263 0 | 25,263 | Form 4 |
31 | FISCHER GERALD B Director | 2014-12-05 15:29:39 | 21,133 0 | 21,133 | Form 4 |
32 | Weber Gordon S. Sr. VP of Legal, GC and Sec. | 2024-12-06 16:44:02 | 21,040 0 | 21,040 | Form 4 |
33 | KEOUGH STEVEN J Sr VP/Gen Mgr Orth/Chf IP Cnsl | 2008-03-25 19:07:41 | 19,943 0 | 19,943 | Form 4 |
34 | BENSON JOHN W Director | 2015-12-22 17:29:47 | 18,565 0 | 18,565 | Form 4 |
35 | Lopez Paul A VP, President - Ophthamology | 2010-02-10 13:14:25 | 18,283 0 | 18,283 | Form 4 |
36 | KELLER KENNETH H Director | 2010-12-02 18:02:52 | 16,528 0 | 16,528 | Form 4 |
37 | MESLOW JOHN A Director | 2010-12-02 18:07:06 | 16,528 0 | 16,528 | Form 4 |
38 | Shoup Michael J VP of Qual, Reg & Clinical | 2010-02-10 13:21:28 | 16,251 0 | 16,251 | Form 4 |
39 | Heine Lisa Wipperman Director | 2025-02-20 16:12:56 | 13,978 0 | 13,978 | Form 4 |
40 | McCormick Shawn Director | 2020-02-18 16:35:56 | 13,428 0 | 13,428 | Form 4 |
41 | NICHOLS JANE M Vice President Marketing | 2004-01-29 16:33:19 | 12,500 0 | 12,500 | Form 4 |
42 | Anderson Aron B VP & Chief Scientific Officer | 2010-02-10 12:47:16 | 12,189 0 | 12,189 | Form 4 |
43 | DURAN LISE W VP of Research | 2010-02-10 12:59:28 | 12,189 0 | 12,189 | Form 4 |
44 | BUHRMASTER ROBERT C Director | 2014-02-06 17:09:17 | 11,672 0 | 11,672 | Form 4 |
45 | Robey Brian L Sr VP, Product Development | 2010-05-18 16:27:07 | 1,233 9,432 | 10,665 | Form 4 |
46 | NELSON TIMOTHY S Director | 2014-12-05 15:32:03 | 10,606 0 | 10,606 | Form 4 |
47 | MELROSE KENDRICK B Director | 2008-11-19 19:19:49 | 10,000 0 | 10,000 | Form 4/A |
48 | WARD SCOTT R Director | 2014-12-05 15:32:44 | 9,783 0 | 9,783 | Form 4 |
49 | Manders John D. VP Finance, Corp. Controller | 2024-12-06 16:42:27 | 8,155 0 | 8,155 | Form 4 |
50 | ASTRY DOUGLAS P Gen Mgr, In Vitro Technologies | 2010-02-10 12:51:59 | 8,126 0 | 8,126 | Form 4 |
51 | Lehman Mark A. Corporate Controller | 2014-11-20 17:20:50 | 6,957 0 | 6,957 | Form 4 |
52 | Sultana Nusrath VP, Clinical Affairs | 2022-02-14 16:41:06 | 6,530 0 | 6,530 | Form 4 |
53 | Ginsberg Peter L VPof Bus Devlpmt & Strat Plan | 2008-05-21 16:35:17 | 5,527 0 | 5,527 | Form 4 |
54 | BRAINERD MARY K Former Director Director | 2014-05-09 17:40:39 | 4,729 0 | 4,729 | Form 4 |
55 | Seibert Amy E. Principal Accounting Officer | 2016-05-02 15:55:08 | 1,645 0 | 1,645 | Form 4 |
56 | Middleton John C. VP, Drug Del, Product Dev | 2010-08-03 14:19:56 | 1,643 0 | 1,643 | Form 4 |
57 | Meckler Jeffrey A See Explanation of Responses | 2010-12-03 18:29:07 | 0 0 | 0 | Form 3 |